US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist

28.330
+0.260+0.93%

Trading May 15 11:24 ET

12.78BMarket Cap15.92P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-40.79%1.53B

-49.18%1.23B

-24.04%1.68B

-14.50%2.91B

-11.10%2.59B

-13.39%2.43B

-17.69%2.22B

28.33%3.4B

-Cash and cash equivalents

-57.33%843M

-72.12%477.01M

-5.56%936.45M

3.09%2.17B

10.28%1.98B

11.01%1.71B

-44.93%991.63M

84.55%2.11B

-Short-term investments

12.56%689.48M

5.54%756.74M

-38.99%747.46M

-43.17%735.01M

-45.30%612.52M

-43.19%717.04M

37.27%1.23B

-14.25%1.29B

Receivables

-42.18%22.23M

0.14%36.65M

8.81%37.91M

-0.34%35.23M

-41.59%38.44M

-46.42%36.6M

-52.60%34.84M

-21.17%35.35M

-Other receivables

-42.18%22.23M

0.14%36.65M

8.81%37.91M

-0.34%35.23M

-41.59%38.44M

-46.42%36.6M

-52.60%34.84M

-21.17%35.35M

Other current assets

9.63%5.01M

-95.80%3.8M

-92.51%6.78M

-84.77%10.22M

-15.18%4.57M

1,265.10%90.52M

911.91%90.52M

454.79%67.12M

Total current assets

-40.72%1.56B

-50.13%1.27B

-26.19%1.73B

-15.71%2.95B

-11.78%2.63B

-11.23%2.55B

-15.62%2.34B

29.41%3.5B

Non current assets

Goodwill and other intangible assets

----

--0

Investments and advances

1.05%14.57B

6.13%15.1B

-7.80%14.11B

-0.45%14.14B

0.15%14.41B

-2.73%14.23B

2.40%15.3B

3.04%14.2B

Other non current assets

-83.99%4.49M

-77.99%6.52M

-33.98%20.21M

-11.98%29.41M

624.29%28.03M

614.81%29.63M

578.03%30.61M

460.60%33.41M

Total non current assets

0.89%14.57B

5.96%15.11B

-7.85%14.13B

-0.48%14.17B

0.32%14.44B

-2.59%14.26B

2.50%15.33B

3.11%14.24B

Total assets

-5.52%16.13B

-2.57%16.38B

-10.28%15.86B

-3.49%17.12B

-1.75%17.07B

-4.01%16.81B

-0.34%17.67B

7.42%17.74B

Liabilities

Current liabilities

Payables

-2.17%102.96M

-4.27%98.32M

-5.34%115.34M

-7.39%118.69M

-14.21%105.24M

-9.55%102.71M

-5.05%121.84M

1.10%128.17M

-accounts payable

73.52%11.55M

91.82%15.17M

-15.42%13.63M

-52.29%5.81M

-0.08%6.66M

40.68%7.91M

75.38%16.11M

29.62%12.18M

-Dividends payable

-7.28%91.41M

-12.29%83.16M

-3.80%101.71M

-2.68%112.88M

-15.02%98.58M

-12.17%94.8M

-11.25%105.73M

-1.18%115.99M

Current accrued expenses

-4.58%12.6M

-4.58%51.68M

-4.58%12.6M

0.00%54.16M

0.00%13.2M

-6.13%54.16M

-89.59%13.2M

-64.58%54.16M

Current debt and capital lease obligation

----

--999.37M

--998.44M

--997.51M

--996.58M

----

-Current debt

----

--999.37M

--998.44M

--997.51M

--996.58M

----

Other current liabilities

--9.02M

-8.27%11.38M

----

--12.4M

----

Current liabilities

-88.85%124.57M

-86.17%161.38M

-88.69%127.93M

542.92%1.17B

722.01%1.12B

581.33%1.17B

343.68%1.13B

-35.80%182.33M

Non current liabilities

Long term debt and capital lease obligation

0.27%6.14B

0.27%6.13B

-13.78%6.13B

-13.78%6.12B

-13.77%6.12B

-13.76%6.11B

21.98%7.11B

-Long term debt

0.27%6.14B

0.27%6.13B

-13.78%6.13B

-13.78%6.12B

-13.77%6.12B

-13.76%6.11B

21.98%7.11B

Derivative product liabilities

----

--9.9M

--35.6M

Other non current liabilities

-73.82%3.22M

-64.00%900K

--11.3M

4.94%8.5M

--12.3M

--2.5M

----

--8.1M

Total non current liabilities

0.12%6.14B

0.24%6.14B

0.29%6.14B

-14.19%6.14B

-13.60%6.14B

-13.74%6.12B

-13.62%6.12B

22.73%7.15B

Total liabilities

-13.58%6.27B

-13.59%6.3B

-13.59%6.27B

-0.33%7.31B

0.21%7.25B

0.29%7.29B

-1.22%7.26B

20.01%7.33B

Shareholders'equity

Share capital

0.00%108K

0.93%108K

1.87%109K

1.89%108K

0.94%107K

1.90%107K

-common stock

0.00%108K

0.93%108K

1.87%109K

1.89%108K

0.94%107K

1.90%107K

Retained earnings

9.50%2.43B

28.14%2.52B

-14.78%2.13B

-7.90%2.25B

-0.35%2.22B

-12.88%1.96B

7.93%2.5B

6.73%2.45B

Paid-in capital

8.96%4.07B

9.42%4.01B

10.29%4.01B

12.90%4.03B

5.54%3.74B

4.52%3.67B

5.17%3.63B

4.54%3.57B

Less: Treasury stock

-6.15%2.65M

-6.31%2.63M

-5.88%2.62M

-4.47%2.63M

3.36%2.83M

3.35%2.81M

3.84%2.79M

3.38%2.75M

Gains losses not affecting retained earnings

----

--0

----

--0

-17.75%16.9M

-54.04%13.18M

Total stockholders'equity

9.17%6.5B

15.96%6.53B

-0.21%6.14B

4.22%6.28B

3.05%5.95B

-2.57%5.63B

6.20%6.15B

5.12%6.03B

Noncontrolling interests

-13.04%3.36B

-8.71%3.56B

-19.19%3.45B

-19.38%3.53B

-11.37%3.87B

-12.85%3.9B

-7.17%4.26B

-6.22%4.38B

Total equity

0.42%9.86B

5.87%10.08B

-7.98%9.59B

-5.71%9.81B

-3.15%9.82B

-7.06%9.53B

0.29%10.42B

0.03%10.41B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-40.79%1.53B	-49.18%1.23B	-49.18%1.23B	-24.04%1.68B	-14.50%2.91B	-11.10%2.59B	-13.39%2.43B	-13.39%2.43B	-17.69%2.22B	28.33%3.4B
-Cash and cash equivalents	-57.33%843M	-72.12%477.01M	-72.12%477.01M	-5.56%936.45M	3.09%2.17B	10.28%1.98B	11.01%1.71B	11.01%1.71B	-44.93%991.63M	84.55%2.11B
-Short-term investments	12.56%689.48M	5.54%756.74M	5.54%756.74M	-38.99%747.46M	-43.17%735.01M	-45.30%612.52M	-43.19%717.04M	-43.19%717.04M	37.27%1.23B	-14.25%1.29B
Receivables	-42.18%22.23M	0.14%36.65M	0.14%36.65M	8.81%37.91M	-0.34%35.23M	-41.59%38.44M	-46.42%36.6M	-46.42%36.6M	-52.60%34.84M	-21.17%35.35M
-Other receivables	-42.18%22.23M	0.14%36.65M	0.14%36.65M	8.81%37.91M	-0.34%35.23M	-41.59%38.44M	-46.42%36.6M	-46.42%36.6M	-52.60%34.84M	-21.17%35.35M
Other current assets	9.63%5.01M	-95.80%3.8M	-95.80%3.8M	-92.51%6.78M	-84.77%10.22M	-15.18%4.57M	1,265.10%90.52M	1,265.10%90.52M	911.91%90.52M	454.79%67.12M
Total current assets	-40.72%1.56B	-50.13%1.27B	-50.13%1.27B	-26.19%1.73B	-15.71%2.95B	-11.78%2.63B	-11.23%2.55B	-11.23%2.55B	-15.62%2.34B	29.41%3.5B
Non current assets
Goodwill and other intangible assets	----	----	----	----	----	----	----	----	--0	--0
Investments and advances	1.05%14.57B	6.13%15.1B	6.13%15.1B	-7.80%14.11B	-0.45%14.14B	0.15%14.41B	-2.73%14.23B	-2.73%14.23B	2.40%15.3B	3.04%14.2B
Other non current assets	-83.99%4.49M	-77.99%6.52M	-77.99%6.52M	-33.98%20.21M	-11.98%29.41M	624.29%28.03M	614.81%29.63M	614.81%29.63M	578.03%30.61M	460.60%33.41M
Total non current assets	0.89%14.57B	5.96%15.11B	5.96%15.11B	-7.85%14.13B	-0.48%14.17B	0.32%14.44B	-2.59%14.26B	-2.59%14.26B	2.50%15.33B	3.11%14.24B
Total assets	-5.52%16.13B	-2.57%16.38B	-2.57%16.38B	-10.28%15.86B	-3.49%17.12B	-1.75%17.07B	-4.01%16.81B	-4.01%16.81B	-0.34%17.67B	7.42%17.74B
Liabilities
Current liabilities
Payables	-2.17%102.96M	-4.27%98.32M	-4.27%98.32M	-5.34%115.34M	-7.39%118.69M	-14.21%105.24M	-9.55%102.71M	-9.55%102.71M	-5.05%121.84M	1.10%128.17M
-accounts payable	73.52%11.55M	91.82%15.17M	91.82%15.17M	-15.42%13.63M	-52.29%5.81M	-0.08%6.66M	40.68%7.91M	40.68%7.91M	75.38%16.11M	29.62%12.18M
-Dividends payable	-7.28%91.41M	-12.29%83.16M	-12.29%83.16M	-3.80%101.71M	-2.68%112.88M	-15.02%98.58M	-12.17%94.8M	-12.17%94.8M	-11.25%105.73M	-1.18%115.99M
Current accrued expenses	-4.58%12.6M	-4.58%51.68M	-4.58%51.68M	-4.58%12.6M	0.00%54.16M	0.00%13.2M	-6.13%54.16M	-6.13%54.16M	-89.59%13.2M	-64.58%54.16M
Current debt and capital lease obligation	----	----	----	----	--999.37M	--998.44M	--997.51M	--997.51M	--996.58M	----
-Current debt	----	----	----	----	--999.37M	--998.44M	--997.51M	--997.51M	--996.58M	----
Other current liabilities	--9.02M	-8.27%11.38M	-8.27%11.38M	----	----	----	--12.4M	--12.4M	----	----
Current liabilities	-88.85%124.57M	-86.17%161.38M	-86.17%161.38M	-88.69%127.93M	542.92%1.17B	722.01%1.12B	581.33%1.17B	581.33%1.17B	343.68%1.13B	-35.80%182.33M
Non current liabilities
Long term debt and capital lease obligation	0.27%6.14B	0.27%6.14B	0.27%6.14B	0.27%6.13B	-13.78%6.13B	-13.78%6.12B	-13.77%6.12B	-13.77%6.12B	-13.76%6.11B	21.98%7.11B
-Long term debt	0.27%6.14B	0.27%6.14B	0.27%6.14B	0.27%6.13B	-13.78%6.13B	-13.78%6.12B	-13.77%6.12B	-13.77%6.12B	-13.76%6.11B	21.98%7.11B
Derivative product liabilities	----	----	----	----	----	----	----	----	--9.9M	--35.6M
Other non current liabilities	-73.82%3.22M	-64.00%900K	-64.00%900K	--11.3M	4.94%8.5M	--12.3M	--2.5M	--2.5M	----	--8.1M
Total non current liabilities	0.12%6.14B	0.24%6.14B	0.24%6.14B	0.29%6.14B	-14.19%6.14B	-13.60%6.14B	-13.74%6.12B	-13.74%6.12B	-13.62%6.12B	22.73%7.15B
Total liabilities	-13.58%6.27B	-13.59%6.3B	-13.59%6.3B	-13.59%6.27B	-0.33%7.31B	0.21%7.25B	0.29%7.29B	0.29%7.29B	-1.22%7.26B	20.01%7.33B
Shareholders'equity
Share capital	0.00%108K	0.93%108K	0.93%108K	0.93%108K	1.87%109K	1.89%108K	0.94%107K	0.94%107K	0.94%107K	1.90%107K
-common stock	0.00%108K	0.93%108K	0.93%108K	0.93%108K	1.87%109K	1.89%108K	0.94%107K	0.94%107K	0.94%107K	1.90%107K
Retained earnings	9.50%2.43B	28.14%2.52B	28.14%2.52B	-14.78%2.13B	-7.90%2.25B	-0.35%2.22B	-12.88%1.96B	-12.88%1.96B	7.93%2.5B	6.73%2.45B
Paid-in capital	8.96%4.07B	9.42%4.01B	9.42%4.01B	10.29%4.01B	12.90%4.03B	5.54%3.74B	4.52%3.67B	4.52%3.67B	5.17%3.63B	4.54%3.57B
Less: Treasury stock	-6.15%2.65M	-6.31%2.63M	-6.31%2.63M	-5.88%2.62M	-4.47%2.63M	3.36%2.83M	3.35%2.81M	3.35%2.81M	3.84%2.79M	3.38%2.75M
Gains losses not affecting retained earnings	----	--0	--0	----	----	----	--0	--0	-17.75%16.9M	-54.04%13.18M
Total stockholders'equity	9.17%6.5B	15.96%6.53B	15.96%6.53B	-0.21%6.14B	4.22%6.28B	3.05%5.95B	-2.57%5.63B	-2.57%5.63B	6.20%6.15B	5.12%6.03B
Noncontrolling interests	-13.04%3.36B	-8.71%3.56B	-8.71%3.56B	-19.19%3.45B	-19.38%3.53B	-11.37%3.87B	-12.85%3.9B	-12.85%3.9B	-7.17%4.26B	-6.22%4.38B
Total equity	0.42%9.86B	5.87%10.08B	5.87%10.08B	-7.98%9.59B	-5.71%9.81B	-3.15%9.82B	-7.06%9.53B	-7.06%9.53B	0.29%10.42B	0.03%10.41B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall